- ETST is dedicated to meeting the need for high-quality products and devices at affordable prices
- The company offers high-purity, top-quality full-spectrum CBD by utilizing seven cannabinoids that work together synergistically
- ETST is empowering women with discreet STI testing through its new, low-cost Hygee medical device kit
Florida-based biotech company Earth Science Tech Inc. (OTCQB: ETST) operates in the fields of hemp cannabinoids, nutraceuticals, pharmaceuticals, medical devices, and research and development. The company is passionate about the products that it offers and is dedicated to providing the highest-quality products and devices at affordable prices to meet a burgeoning global need.
Not all CBD products are created equal. ETST offers the highest purity and quality full-spectrum, high-grade cannabinoids on the market. Utilizing a well-branded product line and strong distribution channels that include online and retail store sales, the company is able to reach a large consumer base.
Three of ETST’s wholly owned subsidiaries focus on the medical, recreational and industrial hemp industries. These include:
- Canna Inno Laboratories Inc. accesses Canadian government funding for the advancement of further product research and development; this subsidiary allows ETST to qualify for grants offered to pharmaceutical innovators.
- Cannabis Therapeutics Inc. focuses on becoming a leader in the development of innovative CBD-based nutraceutical and pharmaceutical products.
- KannaBidoid works within the recreational cannabis space to provide a wide variety of products.
ETST products are unique in that they offer one of the highest CBD profiles of any full-spectrum hemp oil on the market. These exclusive full-spectrum products combine seven cannabinoids (http://cnw.fm/U3xFL), rather than the two to four that are more common in today’s market. All of ETST’s full-spectrum cannabinoid products contain CBD, CBDa, CBG, CBGa, CBN, CBC and CBDV, as well as terpenoids, amino acids, omegas, saponins and flavonoids. These individual elements work together to promote optimal results.
A recent 60-second infomercial (http://cnw.fm/IsE8G) introduces ETST’s CBD product line. The spot highlights the successful results of case studies and points viewers to where they can purchase ETST products online or in local health food stores. Thanks to recent legalizations, the company now offers products in all 50 states, as well as some 40 countries.
In addition to ETST’s work within the medicinal, pharmaceutical and hemp industries, the company is bringing to market cutting-edge pharmaceutical and medical device offerings through wholly owned subsidiary Earth Science Pharmaceutical Inc. This subsidiary focuses on the development of low-cost, non-invasive diagnostic tools, testing processes, medical devices and vaccines for sexually transmitted illnesses.
ETST’s new-to-market medical device, Hygee, was created to fight sexually transmitted infections (STIs). This self-sampling kit empowers women with discretion, enabling them to anonymously test for STIs such as chlamydia.
“No other existing method of collecting genital specimens from women is more convenient or more efficient than Hygee,” Dr. Michel Aube, ETST’s CEO and chief science officer, stated in a news release (http://cnw.fm/NKub6). “Through intentional design, Hygee is a ‘mistake-proof’ medical device with extremely simple instructions that allow any woman, regardless of age or education, the assurance of correctly using the kit on the first try. With roughly 130 million new chlamydia cases diagnosed yearly, according to the WHO, Hygee is dedicated to this area of women’s health.”
The combination of strategic partnerships, high-quality products, a diverse portfolio, solid research and development, and a strong management team comprised of industry experts positions ETST to experience rapid growth in multiple markets.
For more information, visit the company’s website at www.EarthScienceTech.com
NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://cnw.fm/ETST
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
